Last reviewed · How we verify

NCT05579808

Effect of Epidural Analgesia on Labour, Neonatal and Maternal Outcomes.

Completed Last updated 14 October 2022
What this trial tests

trial testing Epidural Analgesia in Labor Pain in 21,808 participants. Completed in 1 September 2021.

Timeline
1 June 2021
Primary endpoint
1 July 2021
1 September 2021

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
StatusCompleted
Study typeOBSERVATIONAL
Enrollment21,808
Start date1 June 2021
Primary completion1 July 2021
Estimated completion1 September 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

Eligibility, female only, with Labor Pain or Delivery Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lumbar epidural analgesia is the most used method for reducing labour pain, but its impact on the duration of the second stage of labour and on neonatal and maternal outcomes remains debated. The aim was of the study is to examine whether epidural analgesia affects the course and the outcomes of labour among patients divided according to the Robson-10 group classification system. Patients of Robson's classes 1, 2a, 3, and 4a were divided into either the epidural analgesia group or the non-epidural analgesia group. A propensity score matching analysis was performed to balance intergroup differences. The primary goal was to analyse the duration of the second stage of labour. The secondary goals were to evaluate neonatal and maternal outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Epidural Analgesia

Trials testing the same drug.

Other recruiting trials for Labor Pain

Currently open trials in the same condition.

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05579808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing